{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T13:02:01Z","timestamp":1790082121791,"version":"4.0.1"},"reference-count":106,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1038\/s41584-026-01412-3","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T15:22:37Z","timestamp":1785511357000},"page":"615-625","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["From psoriatic plaque to synovium: decoding the skin\u2013joint axis in psoriatic arthritis"],"prefix":"10.1038","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2020-6711","authenticated-orcid":false,"given":"Maria Gabriella","family":"Raimondo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saviana","family":"Gandolfo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6314-5336","authenticated-orcid":false,"given":"Lianne S.","family":"Gensler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0518-8386","authenticated-orcid":false,"given":"Ranjeny","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8740-9615","authenticated-orcid":false,"given":"Georg","family":"Schett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7003-501X","authenticated-orcid":false,"given":"Andreas","family":"Ramming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9352-1264","authenticated-orcid":false,"given":"Francesco","family":"Ciccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,31]]},"reference":[{"key":"1412_CR1","first-page":"210","volume":"33","author":"R Scarpa","year":"2006","unstructured":"Scarpa, R., Ayala, F., Caporaso, N. & Olivieri, I. Psoriasis, psoriatic arthritis, or psoriatic disease? J. Rheumatol. 33, 210\u2013212 (2006).","journal-title":"J. Rheumatol."},{"key":"1412_CR2","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/ncprheum0670","volume":"3","author":"C Ritchlin","year":"2007","unstructured":"Ritchlin, C. Psoriatic disease \u2014 from skin to bone. Nat. Clin. Pract. Rheumatol. 3, 698\u2013706 (2007).","journal-title":"Nat. Clin. Pract. Rheumatol."},{"key":"1412_CR3","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1056\/NEJMra1505557","volume":"376","author":"CT Ritchlin","year":"2017","unstructured":"Ritchlin, C. T., Colbert, R. A. & Gladman, D. D. Psoriatic arthritis. N. Engl. J. Med. 376, 957\u2013970 (2017).","journal-title":"N. Engl. J. Med."},{"key":"1412_CR4","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jaad.2018.06.027","volume":"80","author":"F Alinaghi","year":"2019","unstructured":"Alinaghi, F. et al. Prevalence of psoriatic arthritis in patients with psoriasis: a systematic review and meta-analysis of observational and clinical studies. J. Am. Acad. Dermatol. 80, 251\u2013265.e19 (2019).","journal-title":"J. Am. Acad. Dermatol."},{"key":"1412_CR5","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1093\/rheumatology\/keae040","volume":"64","author":"P Karmacharya","year":"2025","unstructured":"Karmacharya, P. et al. Multimorbidity in psoriasis as a risk factor for psoriatic arthritis: a population-based study. Rheumatology 64, 2199\u20132203 (2025).","journal-title":"Rheumatology"},{"key":"1412_CR6","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1093\/bjd\/ljac086","volume":"188","author":"NAL Rosen\u00f8","year":"2023","unstructured":"Rosen\u00f8, N. A. L., L\u00f8rup, E. H., Richardson, C., Alarcon, I. & Egeberg, A. Exploring disease comorbidities and temporal disease progression of psoriasis: an observational, retrospective, multi-database, cohort study. Br. J. Dermatol. 188, 372\u2013379 (2023).","journal-title":"Br. J. Dermatol."},{"key":"1412_CR7","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1136\/ard.2005.039826","volume":"65","author":"F Siannis","year":"2006","unstructured":"Siannis, F., Farewell, V. T., Cook, R. J., Schentag, C. T. & Gladman, D. D. Clinical and radiological damage in psoriatic arthritis. Ann. Rheum. Dis. 65, 478\u2013481 (2006).","journal-title":"Ann. Rheum. Dis."},{"key":"1412_CR8","first-page":"S62","volume":"26","author":"DD Gladman","year":"2008","unstructured":"Gladman, D. D. Mortality in psoriatic arthritis. Clin. Exp. Rheumatol. 26, S62\u2013S65 (2008).","journal-title":"Clin. Exp. Rheumatol."},{"key":"1412_CR9","first-page":"233","volume":"61","author":"FC Wilson","year":"2009","unstructured":"Wilson, F. C. et al. Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: a population-based study. Arthritis Rheumatol. 61, 233\u2013239 (2009).","journal-title":"Arthritis Rheumatol."},{"key":"1412_CR10","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1002\/art.39494","volume":"68","author":"L Eder","year":"2016","unstructured":"Eder, L. et al. The incidence and risk factors for psoriatic arthritis in patients with psoriasis: a prospective cohort study. Arthritis Rheumatol. 68, 915\u2013923 (2016).","journal-title":"Arthritis Rheumatol."},{"key":"1412_CR11","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/art.39973","volume":"69","author":"L Eder","year":"2017","unstructured":"Eder, L. et al. The development of psoriatic arthritis in patients with psoriasis is preceded by a period of nonspecific musculoskeletal symptoms: a prospective cohort study. Arthritis Rheumatol. 69, 622\u2013629 (2017).","journal-title":"Arthritis Rheumatol."},{"key":"1412_CR12","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/s41584-019-0175-0","volume":"15","author":"JU Scher","year":"2019","unstructured":"Scher, J. U., Ogdie, A., Merola, J. F. & Ritchlin, C. Preventing psoriatic arthritis: focusing on patients with psoriasis at increased risk of transition. Nat. Rev. Rheumatol. 15, 153\u2013166 (2019).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1412_CR13","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.3899\/jrheum.201123","volume":"48","author":"S Belman","year":"2021","unstructured":"Belman, S. et al. Psoriasis characteristics for the early detection of psoriatic arthritis. J. Rheumatol. 48, 1559\u20131565 (2021).","journal-title":"J. Rheumatol."},{"key":"1412_CR14","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2024-004314","volume":"10","author":"A Zabotti","year":"2024","unstructured":"Zabotti, A. et al. Risk of developing psoriatic arthritis in psoriasis cohorts with arthralgia: exploring the subclinical psoriatic arthritis stage. RMD Open 10, e004314 (2024).","journal-title":"RMD Open"},{"key":"1412_CR15","doi-asserted-by":"publisher","first-page":"e208","DOI":"10.1016\/S2665-9913(24)00268-6","volume":"7","author":"F Ciccia","year":"2025","unstructured":"Ciccia, F., Gandolfo, S., Caporali, R. & Scher, J. U. Understanding the spectrum from preclinical psoriatic arthritis to early diagnosis of the disease. Lancet Rheumatol. 7, e208\u2013e211 (2025).","journal-title":"Lancet Rheumatol."},{"key":"1412_CR16","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1093\/rheumatology\/keae399","volume":"64","author":"C L\u00f3pez-Medina","year":"2025","unstructured":"L\u00f3pez-Medina, C., McGonagle, D. & Gossec, L. Subclinical psoriatic arthritis and disease interception \u2014 where are we in 2024? Rheumatology 64, 56\u201364 (2025).","journal-title":"Rheumatology"},{"key":"1412_CR17","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/art.43286","volume":"78","author":"LE Durham","year":"2026","unstructured":"Durham, L. E. et al. Linking skin and joint inflammation in psoriatic arthritis through shared CD8+ T cell clones. Arthritis Rheumatol. 78, 152\u2013165 (2026).","journal-title":"Arthritis Rheumatol."},{"key":"1412_CR18","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41590-025-02351-z","volume":"27","author":"MG Raimondo","year":"2026","unstructured":"Raimondo, M. G. et al. Skin-derived myeloid precursors and joint-resident fibroblasts spread psoriatic disease from skin to joints. Nat. Immunol. 27, 35\u201347 (2026).","journal-title":"Nat. Immunol."},{"key":"1412_CR19","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/S0198-8859(99)00034-8","volume":"60","author":"I Tassiulas","year":"1999","unstructured":"Tassiulas, I., Duncan, S. R., Centola, M., Theofilopoulos, A. N. & Boumpas, D. T. Clonal characteristics of T cell infiltrates in skin and synovium of patients with psoriatic arthritis. Hum. Immunol. 60, 479\u2013491 (1999).","journal-title":"Hum. Immunol."},{"key":"1412_CR20","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.ajhg.2015.10.019","volume":"97","author":"PE Stuart","year":"2015","unstructured":"Stuart, P. E. et al. Genome-wide association analysis of psoriatic arthritis and cutaneous psoriasis reveals differences in their genetic architecture. Am. J. Hum. Genet. 97, 816\u2013836 (2015).","journal-title":"Am. J. Hum. Genet."},{"key":"1412_CR21","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1002\/art.33415","volume":"64","author":"R Winchester","year":"2012","unstructured":"Winchester, R. et al. HLA associations reveal genetic heterogeneity in psoriatic arthritis and in the psoriasis phenotype. Arthritis Rheumatol. 64, 1134\u20131144 (2012).","journal-title":"Arthritis Rheumatol."},{"key":"1412_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7046","volume":"6","author":"J Bowes","year":"2015","unstructured":"Bowes, J. et al. Dense genotyping of immune-related susceptibility loci reveals new insights into the genetics of psoriatic arthritis. Nat. Commun. 6, 6046 (2015).","journal-title":"Nat. Commun."},{"key":"1412_CR23","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1136\/ard.2007.073932","volume":"67","author":"E Pattison","year":"2008","unstructured":"Pattison, E., Harrison, B. J., Griffiths, C. E. M., Silman, A. J. & Bruce, I. N. Environmental risk factors for the development of psoriatic arthritis: results from a case\u2013control study. Ann. Rheum. Dis. 67, 672\u2013676 (2008).","journal-title":"Ann. Rheum. Dis."},{"key":"1412_CR24","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.autrev.2014.01.050","volume":"13","author":"E Suzuki","year":"2014","unstructured":"Suzuki, E., Mellins, E. D., Gershwin, M. E., Nestle, F. O. & Adamopoulos, I. E. The IL-23\/IL-17 axis in psoriatic arthritis. Autoimmun. Rev. 13, 496\u2013502 (2014).","journal-title":"Autoimmun. Rev."},{"key":"1412_CR25","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1016\/S0140-6736(18)30830-4","volume":"391","author":"DJ Veale","year":"2018","unstructured":"Veale, D. J. & Fearon, U. The pathogenesis of psoriatic arthritis. Lancet 391, 2273\u20132284 (2018).","journal-title":"Lancet"},{"key":"1412_CR26","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1136\/ard-2023-224148","volume":"82","author":"A Zabotti","year":"2023","unstructured":"Zabotti, A. et al. EULAR points to consider for the definition of clinical and imaging features suspicious for progression from psoriasis to psoriatic arthritis. Ann. Rheum. Dis. 82, 1162\u20131170 (2023).","journal-title":"Ann. Rheum. Dis."},{"key":"1412_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18513-6","volume":"11","author":"F Penkava","year":"2020","unstructured":"Penkava, F. et al. Single-cell sequencing reveals clonal expansions of pro-inflammatory synovial CD8 T cells expressing tissue-homing receptors in psoriatic arthritis. Nat. Commun. 11, 4767 (2020).","journal-title":"Nat. Commun."},{"key":"1412_CR28","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1016\/j.jaci.2020.11.028","volume":"147","author":"J Liu","year":"2021","unstructured":"Liu, J. et al. Single-cell RNA sequencing of psoriatic skin identifies pathogenic Tc17 cell subsets and reveals distinctions between CD8+ T cells in autoimmunity and cancer. J. Allergy Clin. Immunol. 147, 2370\u20132380 (2021).","journal-title":"J. Allergy Clin. Immunol."},{"key":"1412_CR29","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/s41586-019-1263-7","volume":"570","author":"AP Croft","year":"2019","unstructured":"Croft, A. P. et al. Distinct fibroblast subsets drive inflammation and damage in arthritis. Nature 570, 246\u2013251 (2019).","journal-title":"Nature"},{"key":"1412_CR30","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1002\/art.21972","volume":"54","author":"W Taylor","year":"2006","unstructured":"Taylor, W. et al. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheumatol. 54, 2665\u20132673 (2006).","journal-title":"Arthritis Rheumatol."},{"key":"1412_CR31","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/art.41239","volume":"74","author":"D Simon","year":"2022","unstructured":"Simon, D. et al. Association of structural entheseal lesions with an increased risk of progression from psoriasis to psoriatic arthritis. Arthritis Rheumatol. 74, 253\u2013262 (2022).","journal-title":"Arthritis Rheumatol."},{"key":"1412_CR32","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nrrheum.2017.188","volume":"13","author":"G Schett","year":"2017","unstructured":"Schett, G. et al. Enthesitis: from pathophysiology to treatment. Nat. Rev. Rheumatol. 13, 731\u2013741 (2017).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1412_CR33","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41584-025-01326-6","volume":"22","author":"RH Haberman","year":"2025","unstructured":"Haberman, R. H., Ogdie, A., Merola, J. F., Scher, J. U. & Eder, L. The obesity-inflammation axis in psoriatic disease: mechanisms and therapeutic strategies. Nat. Rev. Rheumatol. 22, 151\u2013164 (2025).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1412_CR34","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.rdc.2025.07.001","volume":"51","author":"AB Maharaj","year":"2025","unstructured":"Maharaj, A. B., Eder, L. & Ogdie, A. Obesity and comorbidity management in psoriatic arthritis. Rheum. Dis. Clin. North. Am. 51, e1\u2013e18 (2025).","journal-title":"Rheum. Dis. Clin. North. Am."},{"key":"1412_CR35","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1136\/annrheumdis-2012-202325","volume":"72","author":"L Eder","year":"2013","unstructured":"Eder, L. et al. Serum adipokines in patients with psoriatic arthritis and psoriasis alone and their correlation with disease activity. Ann. Rheum. Dis. 72, 1956\u20131961 (2013).","journal-title":"Ann. Rheum. Dis."},{"key":"1412_CR36","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1001\/archdermatol.2010.141","volume":"146","author":"R Soltani-Arabshahi","year":"2010","unstructured":"Soltani-Arabshahi R. et al. Obesity in early adulthood as a risk factor for psoriatic arthritis. Arch. Dermatol. 146, 721\u2013726 (2010).","journal-title":"Arch. Dermatol."},{"key":"1412_CR37","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1136\/annrheumdis-2012-201299","volume":"71","author":"T Jon Love","year":"2012","unstructured":"Jon Love, T. et al. Obesity and the risk of psoriatic arthritis: a population-based study. Ann. Rheum. Dis. 71, 1273\u20131277 (2012).","journal-title":"Ann. Rheum. Dis."},{"key":"1412_CR38","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1136\/annrheumdis-2011-201273","volume":"71","author":"W Li","year":"2012","unstructured":"Li, W., Han, J. & Qureshi, A. A. Obesity and risk of incident psoriatic arthritis in US women. Ann. Rheum. Dis. 71, 1267\u20131272 (2012).","journal-title":"Ann. Rheum. Dis."},{"key":"1412_CR39","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1002\/art.22758","volume":"56","author":"D McGonagle","year":"2007","unstructured":"McGonagle, D., Lories, R. J. U., Tan, A. L. & Benjamin, M. The concept of a \u2018synovio-entheseal complex\u2019 and its implications for understanding joint inflammation and damage in psoriatic arthritis and beyond. Arthritis Rheumatol. 56, 2482\u20132491 (2007).","journal-title":"Arthritis Rheumatol."},{"key":"1412_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/ard.2007.080952","volume":"67","author":"D McGonagle","year":"2008","unstructured":"McGonagle, D., Tan, A. L. & Benjamin, M. The biomechanical link between skin and joint disease in psoriasis and psoriatic arthritis: what every dermatologist needs to know. Ann. Rheum. Dis. 67, 1\u20134 (2008).","journal-title":"Ann. Rheum. Dis."},{"key":"1412_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06933-4","volume":"9","author":"I Cambr\u00e9","year":"2018","unstructured":"Cambr\u00e9, I. et al. Mechanical strain determines the site-specific localization of inflammation and tissue damage in arthritis. Nat. Commun. 9, 4613 (2018).","journal-title":"Nat. Commun."},{"key":"1412_CR42","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/s41584-019-0364-x","volume":"16","author":"E Gracey","year":"2020","unstructured":"Gracey, E. et al. Tendon and ligament mechanical loading in the pathogenesis of inflammatory arthritis. Nat. Rev. Rheumatol. 16, 193\u2013207 (2020).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1412_CR43","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/nm.2817","volume":"18","author":"JP Sherlock","year":"2012","unstructured":"Sherlock, J. P. et al. IL-23 induces spondyloarthropathy by acting on ROR-\u03b3t+CD3+CD4\u2212CD8\u2212 entheseal resident T cells. Nat. Med. 18, 1069\u20131076 (2012).","journal-title":"Nat. Med."},{"key":"1412_CR44","doi-asserted-by":"publisher","first-page":"3279","DOI":"10.1002\/art.21306","volume":"52","author":"PJ Mease","year":"2005","unstructured":"Mease, P. J. et al. Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: results of a double-blind, randomized, placebo-controlled trial. Arthritis Rheumatol. 52, 3279\u20133289 (2005).","journal-title":"Arthritis Rheumatol."},{"key":"1412_CR45","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/S0140-6736(15)61134-5","volume":"386","author":"IB McInnes","year":"2015","unstructured":"McInnes, I. B. et al. Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 386, 1137\u20131146 (2015).","journal-title":"Lancet"},{"key":"1412_CR46","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1136\/annrheumdis-2016-209709","volume":"76","author":"PJ Mease","year":"2017","unstructured":"Mease, P. J. et al. Ixekizumab, an interleukin-17A specific monoclonal antibody, for the treatment of biologic-naive patients with active psoriatic arthritis: results from the 24-week randomised, double-blind, placebo-controlled and active (adalimumab)-controlled period of the phase III trial SPIRIT-P1. Ann. Rheum. Dis. 76, 79\u201387 (2017).","journal-title":"Ann. Rheum. Dis."},{"key":"1412_CR47","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/S0140-6736(20)30263-4","volume":"395","author":"PJ Mease","year":"2020","unstructured":"Mease, P. J. et al. Guselkumab in biologic-naive patients with active psoriatic arthritis (DISCOVER-2): a double-blind, randomised, placebo-controlled phase 3 trial. Lancet 395, 1126\u20131136 (2020).","journal-title":"Lancet"},{"key":"1412_CR48","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/S0140-6736(20)30265-8","volume":"395","author":"A Deodhar","year":"2020","unstructured":"Deodhar, A. et al. Guselkumab in patients with active psoriatic arthritis who were biologic-naive or had previously received TNF\u03b1 inhibitor treatment (DISCOVER-1): a double-blind, randomised, placebo-controlled phase 3 trial. Lancet 395, 1115\u20131125 (2020).","journal-title":"Lancet"},{"key":"1412_CR49","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2025-005522","volume":"11","author":"LC Coates","year":"2025","unstructured":"Coates, L. C. et al. Efficacy of risankizumab across GRAPPA domains in psoriatic arthritis: a pooled analysis of patients from the phase 3 KEEPsAKE 1 and 2 studies. RMD Open 11, e005522 (2025).","journal-title":"RMD Open"},{"key":"1412_CR50","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s41572-021-00293-y","volume":"7","author":"O FitzGerald","year":"2021","unstructured":"FitzGerald, O. et al. Psoriatic arthritis. Nat. Rev. Dis. Primers 7, 59 (2021).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"1412_CR51","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1038\/jid.2010.103","volume":"130","author":"BB Davidovici","year":"2010","unstructured":"Davidovici, B. B. et al. Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions. J. Invest. Dermatol. 130, 1785\u20131796 (2010).","journal-title":"J. Invest. Dermatol."},{"key":"1412_CR52","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jaad.2016.07.064","volume":"76","author":"J Takeshita","year":"2017","unstructured":"Takeshita, J. et al. Psoriasis and comorbid diseases. J. Am. Acad. Dermatol. 76, 377\u2013390 (2017).","journal-title":"J. Am. Acad. Dermatol."},{"key":"1412_CR53","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/j.1600-0625.2011.01261.x","volume":"20","author":"WH Boehncke","year":"2011","unstructured":"Boehncke, W. H., Boehncke, S., Tobin, A. M. & Kirby, B. The \u2018psoriatic march\u2019: a concept of how severe psoriasis may drive cardiovascular comorbidity. Exp. Dermatol. 20, 303\u2013307 (2011).","journal-title":"Exp. Dermatol."},{"key":"1412_CR54","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1002\/art.42661","volume":"77","author":"L Eder","year":"2025","unstructured":"Eder, L. et al. Derivation of a multivariable psoriatic arthritis risk estimation tool (PRESTO): a step towards prevention. Arthritis Rheumatol. 77, 686\u2013695 (2025).","journal-title":"Arthritis Rheumatol."},{"key":"1412_CR55","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1093\/rheumatology\/kex323","volume":"56","author":"W Tillett","year":"2017","unstructured":"Tillett, W. et al. Interval between onset of psoriasis and psoriatic arthritis comparing the UK clinical practice research datalink with a hospital-based cohort. Rheumatology 56, 2109\u20132113 (2017).","journal-title":"Rheumatology"},{"key":"1412_CR56","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1136\/annrheumdis-2020-217372","volume":"79","author":"JS Smolen","year":"2020","unstructured":"Smolen, J. S. et al. Multicentre, randomised, open-label, parallel-group study evaluating the efficacy and safety of ixekizumab versus adalimumab in patients with psoriatic arthritis na\u00efve to biological disease-modifying antirheumatic drug: final results by week 52. Ann. Rheum. Dis. 79, 1310\u20131319 (2020).","journal-title":"Ann. Rheum. Dis."},{"key":"1412_CR57","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1136\/annrheumdis-2020-218186","volume":"80","author":"A Nerviani","year":"2021","unstructured":"Nerviani, A. et al. IL-23 skin and joint profiling in psoriatic arthritis: novel perspectives in understanding clinical responses to IL-23 inhibitors. Ann. Rheum. Dis. 80, 591\u2013597 (2021).","journal-title":"Ann. Rheum. Dis."},{"key":"1412_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1326502","volume":"15","author":"S Zhang","year":"2024","unstructured":"Zhang, S. et al. Deep analysis of skin molecular heterogeneities and their significance on the precise treatment of patients with psoriasis. Front. Immunol. 15, 1326502 (2024).","journal-title":"Front. Immunol."},{"key":"1412_CR59","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/s41590-024-01774-4","volume":"25","author":"S Rauber","year":"2024","unstructured":"Rauber, S. et al. CD200+ fibroblasts form a pro-resolving mesenchymal network in arthritis. Nat. Immunol. 25, 682\u2013692 (2024).","journal-title":"Nat. Immunol."},{"key":"1412_CR60","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41586-020-2222-z","volume":"582","author":"K Wei","year":"2020","unstructured":"Wei, K. et al. Notch signalling drives synovial fibroblast identity and arthritis pathology. Nature 582, 259\u2013264 (2020).","journal-title":"Nature"},{"key":"1412_CR61","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1038\/s41591-020-0939-8","volume":"26","author":"S Alivernini","year":"2020","unstructured":"Alivernini, S. et al. Distinct synovial tissue macrophage subsets regulate inflammation and remission in rheumatoid arthritis. Nat. Med. 26, 1295\u20131306 (2020).","journal-title":"Nat. Med."},{"key":"1412_CR62","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.ard.2025.08.032","volume":"85","author":"MG Raimondo","year":"2026","unstructured":"Raimondo, M. G. et al. Entheseal tissue signature in response to IL-17A inhibition in psoriatic arthritis: results from the EBIO entheseal biopsy study. Ann. Rheum. Dis. 85, 285\u2013296 (2026).","journal-title":"Ann. Rheum. Dis."},{"key":"1412_CR63","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/s41584-022-00776-6","volume":"18","author":"G Schett","year":"2022","unstructured":"Schett, G. et al. Psoriatic arthritis from a mechanistic perspective. Nat. Rev. Rheumatol. 18, 311\u2013325 (2022).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1412_CR64","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","volume":"397","author":"CEM Griffiths","year":"2021","unstructured":"Griffiths, C. E. M., Armstrong, A. W., Gudjonsson, J. E. & Barker, J. N. W. N. Psoriasis. Lancet 397, 1301\u20131315 (2021).","journal-title":"Lancet"},{"key":"1412_CR65","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1111\/ijd.13699","volume":"56","author":"M Lynch","year":"2017","unstructured":"Lynch, M. et al. Adipokines, psoriasis, systemic inflammation, and endothelial dysfunction. Int. J. Dermatol. 56, 1103\u20131118 (2017).","journal-title":"Int. J. Dermatol."},{"key":"1412_CR66","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1016\/j.jid.2024.02.013","volume":"144","author":"Q Li","year":"2024","unstructured":"Li, Q., Pang, B., Dang, E. & Wang, G. Endothelial dysfunction in psoriasis: an integrative review. J. Invest. Dermatol. 144, 1935\u20131942 (2024).","journal-title":"J. Invest. Dermatol."},{"key":"1412_CR67","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1136\/annrheumdis-2021-221761","volume":"81","author":"A Floudas","year":"2022","unstructured":"Floudas, A. et al. Distinct stromal and immune cell interactions shape the pathogenesis of rheumatoid and psoriatic arthritis. Ann. Rheum. Dis. 81, 1224\u20131242 (2022).","journal-title":"Ann. Rheum. Dis."},{"key":"1412_CR68","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s00296-020-04775-2","volume":"41","author":"S Gupta","year":"2021","unstructured":"Gupta, S., Syrimi, Z., Hughes, D. M. & Zhao, S. S. Comorbidities in psoriatic arthritis: a systematic review and meta-analysis. Rheumatol. Int. 41, 275\u2013284 (2021).","journal-title":"Rheumatol. Int."},{"key":"1412_CR69","doi-asserted-by":"publisher","first-page":"3787","DOI":"10.1007\/s10067-025-07637-z","volume":"44","author":"S Andreasson","year":"2025","unstructured":"Andreasson, S. & S\u00f6dergren, A. Prevalence of metabolic syndrome and its components in psoriatic arthritis compared with general population, cutaneous psoriasis, and other inflammatory arthropathies: a meta-analysis. Clin. Rheumatol. 44, 3787\u20133799 (2025).","journal-title":"Clin. Rheumatol."},{"key":"1412_CR70","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1007\/s10067-022-06484-6","volume":"42","author":"HH Gezer","year":"2023","unstructured":"Gezer, H. H., Acer Kasman, S. & Duru\u00f6z, M. T. Autonomic dysfunction and cardiovascular risk in psoriatic arthritis. Clin. Rheumatol. 42, 2635\u20132649 (2023).","journal-title":"Clin. Rheumatol."},{"key":"1412_CR71","doi-asserted-by":"publisher","first-page":"411","DOI":"10.2147\/PTT.S535900","volume":"15","author":"L Tang","year":"2025","unstructured":"Tang, L. et al. The skin\u2013brain axis in psoriasis and depression: roles of inflammation, hormones, neuroendocrine pathways, neuropeptides, and the microbiome. Psoriasis 15, 411\u2013428 (2025).","journal-title":"Psoriasis"},{"key":"1412_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychores.2023.111350","volume":"170","author":"A Rajasekharan","year":"2023","unstructured":"Rajasekharan, A. et al. Stress and psoriasis: exploring the link through the prism of hypothalamo\u2013pituitary\u2013adrenal axis and inflammation. J. Psychosom. Res. 170, 111350 (2023).","journal-title":"J. Psychosom. Res."},{"key":"1412_CR73","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1136\/annrheumdis-2014-205461","volume":"75","author":"M Haroon","year":"2016","unstructured":"Haroon, M., Winchester, R., Giles, J. T., Heffernan, E. & FitzGerald, O. Certain class I HLA alleles and haplotypes implicated in susceptibility play a role in determining specific features of the psoriatic arthritis phenotype. Ann. Rheum. Dis. 75, 155\u2013162 (2016).","journal-title":"Ann. Rheum. Dis."},{"key":"1412_CR74","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1002\/art.42654","volume":"75","author":"OF Cruz-Correa","year":"2023","unstructured":"Cruz-Correa, O. F., Pollock, R. A., Machhar, R. & Gladman, D. D. Prediction of psoriatic arthritis in patients with psoriasis using DNA methylation profiles. Arthritis Rheumatol. 75, 2178\u20132184 (2023).","journal-title":"Arthritis Rheumatol."},{"key":"1412_CR75","doi-asserted-by":"publisher","DOI":"10.1002\/art.70193","author":"EB Prideaux","year":"2026","unstructured":"Prideaux, E. B. et al. Association of epigenetic trajectory with development of clinical rheumatoid arthritis in individuals with anti-citrullinated protein antibody positivity: targeting immune responses for prevention of rheumatoid arthritis (TIP-RA). Arthritis Rheumatol. https:\/\/doi.org\/10.1002\/art.70193 (2026).","journal-title":"Arthritis Rheumatol."},{"key":"1412_CR76","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1016\/j.immuni.2025.08.006","volume":"58","author":"C Wang","year":"2025","unstructured":"Wang, C. et al. Gut microbe-derived metabolites drive psoriatic inflammation via modulation of skin TH17 cells. Immunity 58, 2241\u20132255.e7 (2025).","journal-title":"Immunity"},{"key":"1412_CR77","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-47310-5","volume":"9","author":"M Diani","year":"2019","unstructured":"Diani, M. et al. Increased frequency of activated CD8+ T cell effectors in patients with psoriatic arthritis. Sci. Rep. 9, 10870 (2019).","journal-title":"Sci. Rep."},{"key":"1412_CR78","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jaut.2016.03.019","volume":"70","author":"F Sgambelluri","year":"2016","unstructured":"Sgambelluri, F. et al. A role for CCR5+CD4 T cells in cutaneous psoriasis and for CD103+CCR4+CD8 Teff cells in the associated systemic inflammation. J. Autoimmunity 70, 80\u201390 (2016).","journal-title":"J. Autoimmunity"},{"key":"1412_CR79","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202149702","volume":"53","author":"G Montico","year":"2023","unstructured":"Montico, G. et al. CCR4+ CD8+ T cells clonally expand to differentiated effectors in murine psoriasis and in human psoriatic arthritis. Eur. J. Immunol. 53, 2149702 (2023).","journal-title":"Eur. J. Immunol."},{"key":"1412_CR80","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41586-025-08713-9","volume":"641","author":"CA Donado","year":"2025","unstructured":"Donado, C. A. et al. Granzyme K activates the entire complement cascade. Nature 641, 211\u2013221 (2025).","journal-title":"Nature"},{"key":"1412_CR81","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1002\/art.41652","volume":"73","author":"EF Leijten","year":"2021","unstructured":"Leijten, E. F. et al. Tissue-resident memory CD8+ T cells from skin differentiate psoriatic arthritis from psoriasis. Arthritis Rheumatol. 73, 1220\u20131232 (2021).","journal-title":"Arthritis Rheumatol."},{"key":"1412_CR82","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/nri.2015.3","volume":"16","author":"SN Mueller","year":"2016","unstructured":"Mueller, S. N. & Mackay, L. K. Tissue-resident memory T cells: local specialists in immune defence. Nat. Rev. Immunol. 16, 79\u201389 (2016).","journal-title":"Nat. Rev. Immunol."},{"key":"1412_CR83","doi-asserted-by":"publisher","unstructured":"Dong, C. et al. CXCR6 sustains TRM-driven psoriasis relapse by CXCL16 chemotaxis and curcumol targeting. J. Adv. Res.\u00a0https:\/\/doi.org\/10.1016\/j.jare.2025.10.066\u00a0(2025).","DOI":"10.1016\/j.jare.2025.10.066"},{"key":"1412_CR84","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.it.2015.07.002","volume":"36","author":"N Iijima","year":"2015","unstructured":"Iijima, N. & Iwasaki, A. Tissue instruction for migration and retention of TRM cells. Trends Immunol. 36, 556\u2013564 (2015).","journal-title":"Trends Immunol."},{"key":"1412_CR85","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-216456","volume":"80","author":"G Guggino","year":"2021","unstructured":"Guggino, G., Rizzo, A., Mauro, D., Macaluso, F. & Ciccia, F. Gut-derived CD8+ tissue-resident memory T cells are expanded in the peripheral blood and synovia of SpA patients. Ann. Rheum. Dis. 80, e174 (2021).","journal-title":"Ann. Rheum. Dis."},{"key":"1412_CR86","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1136\/annrheumdis-2019-215349","volume":"78","author":"Z Qaiyum","year":"2019","unstructured":"Qaiyum, Z., Gracey, E., Yao, Y. & Inman, R. D. Integrin and transcriptomic profiles identify a distinctive synovial CD8+ T cell subpopulation in spondyloarthritis. Ann. Rheum. Dis. 78, 1566\u20131575 (2019).","journal-title":"Ann. Rheum. Dis."},{"key":"1412_CR87","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.178213","volume":"9","author":"CT Ritchlin","year":"2024","unstructured":"Ritchlin, C. T. et al. Psoriatic arthritis subtypes are phenocopied in humanized mice. JCI Insight 9, e178213 (2024).","journal-title":"JCI Insight"},{"key":"1412_CR88","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1002\/art.43396","volume":"78","author":"H Gra\u00dfhoff","year":"2026","unstructured":"Gra\u00dfhoff, H. et al. Transition from psoriasis to psoriatic arthritis is characterized by distinct alterations in peripheral blood Tc17, Th17, and CD4+ effector memory cells. Arthritis Rheumatol. 78, 332\u2013343 (2026).","journal-title":"Arthritis Rheumatol."},{"key":"1412_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.110528","volume":"27","author":"A Giovenzana","year":"2024","unstructured":"Giovenzana, A., Codazzi, V., Pandolfo, M. & Petrelli, A. T cell trafficking in human chronic inflammatory diseases. iScience 27, 110528 (2024).","journal-title":"iScience"},{"key":"1412_CR90","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.188028","volume":"10","author":"B Cai","year":"2025","unstructured":"Cai, B. et al. Proinflammatory macrophages transporting gut-derived bacterial DNA drive autoimmune arthritis in spondyloarthropathy. JCI Insight 10, e188028 (2025).","journal-title":"JCI Insight"},{"key":"1412_CR91","doi-asserted-by":"publisher","first-page":"951","DOI":"10.4049\/jimmunol.1003986","volume":"187","author":"IE Adamopoulos","year":"2011","unstructured":"Adamopoulos, I. E. et al. IL-23 is critical for induction of arthritis, osteoclast formation, and maintenance of bone mass. J. Immunol. 187, 951\u2013959 (2011).","journal-title":"J. Immunol."},{"key":"1412_CR92","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0247149","volume":"16","author":"EK Haley","year":"2021","unstructured":"Haley, E. K. et al. The impact of genetic background and sex on the phenotype of IL-23 induced murine spondyloarthritis. PLoS ONE 16, e0247149 (2021).","journal-title":"PLoS ONE"},{"key":"1412_CR93","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-65269-6","volume":"10","author":"L Chen","year":"2020","unstructured":"Chen, L. et al. Skin expression of IL-23 drives the development of psoriasis and psoriatic arthritis in mice. Sci. Rep. 10, 8259 (2020).","journal-title":"Sci. Rep."},{"key":"1412_CR94","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.3389\/fimmu.2018.02641","volume":"9","author":"Y Chen","year":"2018","unstructured":"Chen, Y. et al. Silencing SOCS3 markedly deteriorates spondyloarthritis in mice induced by minicircle DNA expressing IL23. Front. Immunol. 9, 2641 (2018).","journal-title":"Front. Immunol."},{"key":"1412_CR95","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/s41586-023-06708-y","volume":"623","author":"F Zhang","year":"2023","unstructured":"Zhang, F. et al. Deconstruction of rheumatoid arthritis synovium defines inflammatory subtypes. Nature 623, 616\u2013624 (2023).","journal-title":"Nature"},{"key":"1412_CR96","doi-asserted-by":"publisher","unstructured":"Tynan, \u00d3 et al. RA and PsA synovial tissue single-cell analysis demonstrates differential fibroblast populations with distinct phenotypes and functional capacities. Ann. Rheum. Dis. https:\/\/doi.org\/10.1016\/j.ard.2026.03.010\u00a0(2026).","DOI":"10.1016\/j.ard.2026.03.010"},{"key":"1412_CR97","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.immuni.2021.04.021","volume":"54","author":"MB Buechler","year":"2021","unstructured":"Buechler, M. B., Fu, W. & Turley, S. J. Fibroblast\u2013macrophage reciprocal interactions in health, fibrosis, and cancer. Immunity 54, 903\u2013915 (2021).","journal-title":"Immunity"},{"key":"1412_CR98","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1038\/s41590-023-01527-9","volume":"24","author":"MH Smith","year":"2023","unstructured":"Smith, M. H. et al. Drivers of heterogeneity in synovial fibroblasts in rheumatoid arthritis. Nat. Immunol. 24, 1200\u20131210 (2023).","journal-title":"Nat. Immunol."},{"key":"1412_CR99","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/s41584-024-01107-7","volume":"20","author":"MH Chang","year":"2024","unstructured":"Chang, M. H., Fuhlbrigge, R. C. & Nigrovic, P. A. Joint-specific memory, resident memory T cells and the rolling window of opportunity in arthritis. Nat. Rev. Rheumatol. 20, 258\u2013271 (2024).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1412_CR100","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s13075-021-02545-4","volume":"23","author":"MLM Mulder","year":"2021","unstructured":"Mulder, M. L. M. et al. Clinical, laboratory, and genetic markers for the development or presence of psoriatic arthritis in psoriasis patients: a systematic review. Arthritis Res. Ther. 23, 168 (2021).","journal-title":"Arthritis Res. Ther."},{"key":"1412_CR101","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1136\/ard-2022-223389","volume":"82","author":"A Boix-Amor\u00f3s","year":"2023","unstructured":"Boix-Amor\u00f3s, A. et al. Alterations in the cutaneous microbiome of patients with psoriasis and psoriatic arthritis reveal similarities between non-lesional and lesional skin. Ann. Rheum. Dis. 82, 507\u2013514 (2023).","journal-title":"Ann. Rheum. Dis."},{"key":"1412_CR102","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1080\/09546634.2021.1942423","volume":"33","author":"AB Gottlieb","year":"2022","unstructured":"Gottlieb, A. B. & Merola, J. F. A clinical perspective on risk factors and signs of subclinical and early psoriatic arthritis among patients with psoriasis. J. Dermatol. Treat. 33, 1907\u20131915 (2022).","journal-title":"J. Dermatol. Treat."},{"key":"1412_CR103","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1093\/rheumatology\/kei207","volume":"45","author":"T Garrood","year":"2006","unstructured":"Garrood, T., Lee, L. & Pitzalis, C. Molecular mechanisms of cell recruitment to inflammatory sites: general and tissue-specific pathways. Rheumatology 45, 250\u2013260 (2006).","journal-title":"Rheumatology"},{"key":"1412_CR104","doi-asserted-by":"publisher","first-page":"271","DOI":"10.4049\/jimmunol.1901077","volume":"204","author":"J Kolter","year":"2020","unstructured":"Kolter, J., Kierdorf, K. & Henneke, P. Origin and differentiation of nerve-associated macrophages. J. Immunol. 204, 271\u2013279 (2020).","journal-title":"J. Immunol."},{"key":"1412_CR105","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s41927-025-00468-0","volume":"9","author":"F Alnaimat","year":"2025","unstructured":"Alnaimat, F. et al. Psoriatic arthritis in Jordan: a cross-sectional study of disease characteristics, patient-reported outcomes, and disease activity. BMC Rheumatol. 9, 16 (2025).","journal-title":"BMC Rheumatol."},{"key":"1412_CR106","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1016\/j.jid.2021.09.038","volume":"142","author":"LC Tsoi","year":"2022","unstructured":"Tsoi, L. C. et al. Noninvasive tape-stripping with high-resolution RNA profiling effectively captures a preinflammatory state in nonlesional psoriatic skin. J. Invest. Dermatol. 142, 1587\u20131596.e2 (2022).","journal-title":"J. Invest. Dermatol."}],"container-title":["Nature Reviews Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41584-026-01412-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41584-026-01412-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41584-026-01412-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T12:02:03Z","timestamp":1790078523000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41584-026-01412-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,31]]},"references-count":106,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["1412"],"URL":"https:\/\/doi.org\/10.1038\/s41584-026-01412-3","relation":{},"ISSN":["1759-4790","1759-4804"],"issn-type":[{"value":"1759-4790","type":"print"},{"value":"1759-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,31]]},"assertion":[{"value":"3 July 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}